Related by context. Frequent words. (Click for all words.) 73 MKC# 72 Panzem R 71 VEGFR2 inhibitor 69 peripherally acting 68 liposomal formulation 68 REGN# 68 AEG# 68 Tesetaxel 68 Belimumab 68 Saxagliptin 67 nicotinic alpha 7 67 2 methoxyestradiol 67 R sorafenib tablets 67 Voreloxin 67 inhaled formulation 67 multi kinase inhibitor 67 Factor VIIa 67 Panzem R NCD 67 Dapagliflozin 67 huC# DM4 66 proteasome inhibitor 66 Cetrorelix 66 includes investigational compounds 66 Mipomersen 66 gonadotropin releasing hormone GnRH 66 Lubiprostone 66 TLR9 agonist 66 pegylated 66 Interferon alpha 66 GSK# [002] 65 MEK inhibitor 65 Thiarabine 65 novel orally administered 65 fluoroquinolone class 65 DNA RNA Medicines 65 Nanobody 65 rheumatoid arthritis psoriatic arthritis 65 Pazopanib 65 Currently RegeneRx 65 PD LID 65 Initiates Phase II 65 Sapacitabine 65 PSMA ADC 65 PEG SN# 65 Completes Patient Enrollment 64 Emergent marketed 64 subcutaneously administered 64 products Oncaspar 64 injectable formulation 64 epothilone 64 humanized anti 64 Prodarsan ® 64 Potassium Chloride Sodium Ascorbate 64 based pretargeting methods 64 Commences Phase 64 specific ZFP Nucleases 64 anticancer compound 64 histone deacetylase HDAC inhibitor 64 Phase Ib clinical trials 64 PSN# [002] 64 Linaclotide 64 Daclizumab 64 Nexavar ® 64 SERMs 64 phenylalanine ammonia lyase 64 Dasatinib 64 topical non steroidal 64 CORT # 64 fusion inhibitor 64 BiTE R 64 developing Zerenex TM 64 Xanafide 64 PEGylated 64 candidate AP# 64 polymerase inhibitor 64 KNS # 63 Ofatumumab 63 non alcoholic steatohepatitis 63 Phase Ib IIa 63 JAK1 63 polymerase inhibitors 63 Genasense ® oblimersen 63 transcriptase inhibitor NNRTI 63 HCV protease inhibitor 63 partial agonist 63 5 HT3 receptor 63 Elesclomol 63 Shigamabs ® 63 Blinatumomab 63 Phase IIb clinical trials 63 SAR# [004] 63 Lu AA# 63 Vytorin combines 63 CDP# 63 Zolinza 63 Vaprisol 63 nitric oxide donating 63 LY# [003] 63 metformin sulfonylurea 63 Pivotal Phase 63 EZN